Vascular BD or HSS respond generally to glucocorticoids and cyclophosphamide, or anti-TNFα in refractory cases, or in cases with pulmonary vessel involvement [19,71,129]. This evidence concerns the gene TNF and Hallermann-Streiff syndrome.